News & Blog
Connect with CHERISH investigators, CHERISH Research Affiliates, Advisory Board members, and pilot grant recipients in person as they present their research in upcoming June conferences. Use the following schedule to explore the breadth of their work.
The Center for Health Economics of Treatment Interventions for Substance Use Disorder, HCV, and HIV (CHERISH) is proud to welcome Margaret Lowenstein, assistant professor at the Perelman School of Medicine and senior fellow at the Leonard Davis Institute of Health Economics (LDI) at the University of Pennsylvania, as the new co-director of the Dissemination and Policy Core. Lowenstein succeeds Janet Weiner who retired earlier this year.
These findings on patient perspectives and experiences using naloxone indicate that emergency departments represent an opportunity to improve naloxone carrying. These early insights are key in helping quality improvement, operational, and administrative efforts to support addiction-based care and to save lives within the community.
During the COVID-19 pandemic, low-barrier care provided vital services and treatment to people with opioid use disorder. In this recap, fellow speakers share new approaches that can continue the momentum and reduce the toll of opioid overdose deaths.
Coming to New York City was an easy decision for Harkness Fellow Ane-Kristine Finbraten. The city has one of the most robust hepatitis C elimination efforts to learn from.
The development of direct-acting antivirals transformed hepatitis C virus (HCV) therapy, allowing patients to experience fewer side effects and non-specialist providers to prescribe HCV treatment with more ease. Despite these advances, existing social and structural barriers, such as stigma and accessibility of medical care, restrict access to effective HCV treatment for people who use drugs who are co-infected with HIV and HCV.